BIOMAT Database Logo BIOMAT Database Logo

The potassium channel opener BRL 38227 inhibits binding of [125I]-labelled endothelin-1 to rat cardiac membranes. 1992

C J Waugh, and M E Dockrell, and W G Haynes, and H J Olverman, and B C Williams, and D J Webb
Edinburgh University Department of Medicine, Western General Hospital.

Binding of [125I]-labelled endothelin-1 (ET-1) to rat cardiac membranes and the effects of endothelin-1 (ET-1), endothelin-3 (ET-3), the calcium channel antagonist nifedipine, and both enantiomers of the potassium channel opener cromakalim (BRL 34915) on binding have been examined. Specific binding of [125I]-ET-1 was inhibited in a concentration dependent manner by both unlabelled ET-1 (10(-12)-10(-7) M) and ET-3 (10(-12)-10(-6) M). Nifedipine (10(-11)-10(-5) M) did not affect [125I]-ET-1 binding. However, BRL 38227 (10(-11)-10(-5) M), the biologically active isomer of cromakalim, significantly inhibited [125I]-ET-1 binding. The inactive isomer, BRL 38226 (10(-11)-10(-5) M) had no effect. These findings provide the first evidence for a stereospecific interaction between BRL 38227 and an ET-1 binding site in rat cardiac membranes.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001578 Benzopyrans Compounds with a core of fused benzo-pyran rings. Benzopyran,Chromene,Chromenes
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D012508 Sarcolemma The excitable plasma membrane of a muscle cell. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Sarcolemmas
D015221 Potassium Channels Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits. Ion Channels, Potassium,Ion Channel, Potassium,Potassium Channel,Potassium Ion Channels,Channel, Potassium,Channel, Potassium Ion,Channels, Potassium,Channels, Potassium Ion,Potassium Ion Channel
D015640 Ion Channel Gating The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential (voltage-gated), drugs or chemical transmitters (ligand-gated), or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability. Gating, Ion Channel,Gatings, Ion Channel,Ion Channel Gatings
D016232 Endothelins 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides. Endothelium-Derived Vasoconstrictor Factors,Endothelin,Vasoconstrictor Factors, Endothelium-Derived

Related Publications

C J Waugh, and M E Dockrell, and W G Haynes, and H J Olverman, and B C Williams, and D J Webb
BRL 38227--a potassium channel opener, antagonizes digoxin-induced convulsions.
July 1993, Pharmacology & toxicology,
C J Waugh, and M E Dockrell, and W G Haynes, and H J Olverman, and B C Williams, and D J Webb
Preferential small arteriolar vasodilatation by the potassium channel opener, BRL 38227, in conscious spontaneously hypertensive rats.
July 1992, European journal of pharmacology,
C J Waugh, and M E Dockrell, and W G Haynes, and H J Olverman, and B C Williams, and D J Webb
Specific high-affinity binding sites for 125I-labelled porcine endothelin in rat cardiac membranes.
August 1989, European journal of pharmacology,
C J Waugh, and M E Dockrell, and W G Haynes, and H J Olverman, and B C Williams, and D J Webb
Inhibitory action of the potassium channel opener BRL 38227 on agonist-stimulated phosphoinositide metabolism in bovine tracheal smooth muscle.
January 1992, Biochemical pharmacology,
C J Waugh, and M E Dockrell, and W G Haynes, and H J Olverman, and B C Williams, and D J Webb
Ischemia and reperfusion increase 125I-labeled endothelin-1 binding in rat cardiac membranes.
March 1990, The American journal of physiology,
C J Waugh, and M E Dockrell, and W G Haynes, and H J Olverman, and B C Williams, and D J Webb
Reoxygenation, but neither hypoxia nor intermittent ischemia, increases [125I]endothelin-1 binding to rat cardiac membranes.
March 1990, Journal of cardiovascular pharmacology,
C J Waugh, and M E Dockrell, and W G Haynes, and H J Olverman, and B C Williams, and D J Webb
Electrophysiologic and arrhythmogenic effects of the potassium channel agonist BRL 38227 in anesthetized dogs.
November 1993, Journal of cardiovascular pharmacology,
C J Waugh, and M E Dockrell, and W G Haynes, and H J Olverman, and B C Williams, and D J Webb
Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors.
August 1996, British journal of pharmacology,
C J Waugh, and M E Dockrell, and W G Haynes, and H J Olverman, and B C Williams, and D J Webb
Nucleotide regulation and characteristics of potassium channel opener binding to skeletal muscle membranes.
September 1997, Molecular pharmacology,
C J Waugh, and M E Dockrell, and W G Haynes, and H J Olverman, and B C Williams, and D J Webb
Characterization of potassium currents modulated by BRL 38227 in rat portal vein.
July 1992, British journal of pharmacology,
Copied contents to your clipboard!